Country Trust Bank’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-293
Closed -$45.1K 389
2024
Q1
$45.1K Sell
293
-58
-17% -$8.84K ﹤0.01% 175
2023
Q4
$55.5K Sell
351
-520
-60% -$74.7K ﹤0.01% 166
2023
Q3
$127K Buy
871
+58
+7% +$8.84K ﹤0.01% 133
2023
Q2
$125K Hold
813
﹤0.01% 132
2023
Q1
$126K Sell
813
-50
-6% -$7.85K ﹤0.01% 131
2022
Q4
$133K Hold
863
﹤0.01% 134
2022
Q3
$114K Hold
863
﹤0.01% 135
2022
Q2
$117K Hold
863
﹤0.01% 138
2022
Q1
$129K Hold
863
﹤0.01% 148
2021
Q4
$140K Hold
863
﹤0.01% 156
2021
Q3
$143K Hold
863
﹤0.01% 149
2021
Q2
$149K Hold
863
﹤0.01% 144
2021
Q1
$139K Hold
863
﹤0.01% 147
2020
Q4
$145K Hold
863
0.01% 137
2020
Q3
$136K Buy
+863
New +$141K 0.01% 129

Other funds holding FBT

Country Trust Bank's FBT Position: Q2 2024 in Review

Country Trust Bank sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2024, closing a stake of 293 shares — an estimated $45.1K sold.

Country Trust Bank first reported a position in FBT in Q3 2020 and held it in 15 quarters. The position peaked at $149K in Q2 2021. 251 funds tracked by Wall St. Rank hold FBT as of Q2 2024.

  • Country Trust Bank reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2024 after selling out during the quarter.
  • Country Trust Bank sold 293 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2024, an estimated $45.1K.
  • Country Trust Bank first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2020 and held it in 15 quarters.
  • Country Trust Bank's First Trust NYSE Arca Biotechnology Index Fund position peaked at $149K in Q2 2021.
  • 251 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2024.

Based on Country Trust Bank's 13F filing for Q2 2024, filed 12 Jul 2024.